Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-and update on the status. Military Med Research. [internet] 2020 March 16 [cited 1 April 2020];7:11. Available from: http://www.dx.doi.org/10.1186/s40779-020-00240-0

Gao J, Tian Z, Yang X. Breakthrough:chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends [internet] 2020 Feb 19 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.5582/bst.2020.01047

Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, et al. Arguments in favour of remdesivir for treating SARS/CoV/2 infections. Int J Antimicrob Agents. [internet] 2020 March 16 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1016/j.ijantimicag.2020.105933

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New Engl J Med. [internet] 2020 Jan 31 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1056/NEJMoa2001191

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. New Engl J Med. [internet] 2020 March 18 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1056/NEJMoa2001282